Aurinia Pharmaceuticals Inc.
AUPH
$8.18
$0.080.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -11.66% | 18.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.66% | 18.50% | |||
| Cost of Revenue | 50.40% | -30.08% | |||
| Gross Profit | -21.27% | 32.77% | |||
| SG&A Expenses | -12.59% | -5.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -69.52% | 1,677.24% | |||
| Total Operating Expenses | -7.03% | -2.79% | |||
| Operating Income | -33.76% | 2,763.95% | |||
| Income Before Tax | -92.08% | 901.83% | |||
| Income Tax Expenses | -156.02% | -39.55% | |||
| Earnings from Continuing Operations | -90.04% | 1,887.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -90.04% | 1,887.53% | |||
| EBIT | -33.76% | 2,763.95% | |||
| EBITDA | -24.02% | 278.03% | |||
| EPS Basic | -89.93% | 1,906.00% | |||
| Normalized Basic EPS | 12.21% | 482.88% | |||
| EPS Diluted | -89.90% | 1,900.00% | |||
| Normalized Diluted EPS | 10.08% | 472.07% | |||
| Average Basic Shares Outstanding | -0.61% | -0.19% | |||
| Average Diluted Shares Outstanding | 1.39% | 1.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||